Trevi Therapeutics Inc
XNAS: TRVI
Trevi Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary f...
Read More
7.25
0.04
(0.55%)
1.6M
XNAS Volume
High vol. this week
XNAS 29 Aug, 2025 4:01 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Trevi Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..